- Home
- ELDN vs MCR Comparison
ELDN vs MCR Comparison
Compare ELDN & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- MCR
- Stock Information
- Founded
- ELDN 2004
- MCR 1989
- Country
- ELDN United States
- MCR United States
- Employees
- ELDN N/A
- MCR N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- ELDN Health Care
- MCR Finance
- Exchange
- ELDN Nasdaq
- MCR Nasdaq
- Market Cap
- ELDN 232.4M
- MCR 266.0M
- IPO Year
- ELDN N/A
- MCR N/A
- Fundamental
- Price
- ELDN $3.39
- MCR $6.27
- Analyst Decision
- ELDN Strong Buy
- MCR
- Analyst Count
- ELDN 1
- MCR 0
- Target Price
- ELDN $16.00
- MCR N/A
- AVG Volume (30 Days)
- ELDN 261.8K
- MCR 66.7K
- Earning Date
- ELDN 03-20-2025
- MCR 01-01-0001
- Dividend Yield
- ELDN N/A
- MCR 8.52%
- EPS Growth
- ELDN N/A
- MCR N/A
- EPS
- ELDN N/A
- MCR 0.38
- Revenue
- ELDN N/A
- MCR N/A
- Revenue This Year
- ELDN N/A
- MCR N/A
- Revenue Next Year
- ELDN N/A
- MCR N/A
- P/E Ratio
- ELDN N/A
- MCR $16.61
- Revenue Growth
- ELDN N/A
- MCR N/A
- 52 Week Low
- ELDN $1.52
- MCR $5.63
- 52 Week High
- ELDN $5.54
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- ELDN 32.13
- MCR 42.61
- Support Level
- ELDN $3.22
- MCR $6.24
- Resistance Level
- ELDN $3.44
- MCR $6.32
- Average True Range (ATR)
- ELDN 0.18
- MCR 0.05
- MACD
- ELDN -0.01
- MCR 0.00
- Stochastic Oscillator
- ELDN 20.31
- MCR 58.33
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.